These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30754665)

  • 1. Investigating the Role of Everolimus in mTOR Inhibition and Autophagy Promotion as a Potential Host-Directed Therapeutic Target in
    Cerni S; Shafer D; To K; Venketaraman V
    J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30754665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harnessing the mTOR Pathway for Tuberculosis Treatment.
    Singh P; Subbian S
    Front Microbiol; 2018; 9():70. PubMed ID: 29441052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimycobacterial Effects of Everolimus in a Human Granuloma Model.
    Ashley D; Hernandez J; Cao R; To K; Yegiazaryan A; Abrahem R; Nguyen T; Owens J; Lambros M; Subbian S; Venketaraman V
    J Clin Med; 2020 Jun; 9(7):. PubMed ID: 32610643
    [No Abstract]   [Full Text] [Related]  

  • 4. New insights into the evasion of host innate immunity by Mycobacterium tuberculosis.
    Chai Q; Wang L; Liu CH; Ge B
    Cell Mol Immunol; 2020 Sep; 17(9):901-913. PubMed ID: 32728204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy: A new strategy for host-directed therapy of tuberculosis.
    Paik S; Kim JK; Chung C; Jo EK
    Virulence; 2019 Dec; 10(1):448-459. PubMed ID: 30322337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host-Directed Therapy as a Novel Treatment Strategy to Overcome Tuberculosis: Targeting Immune Modulation.
    Ahmed S; Raqib R; Guðmundsson GH; Bergman P; Agerberth B; Rekha RS
    Antibiotics (Basel); 2020 Jan; 9(1):. PubMed ID: 31936156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Macrophage Response to
    Maphasa RE; Meyer M; Dube A
    Front Cell Infect Microbiol; 2020; 10():618414. PubMed ID: 33628745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimycobacterial and Anti-inflammatory Mechanisms of Baicalin via Induced Autophagy in Macrophages Infected with
    Zhang Q; Sun J; Wang Y; He W; Wang L; Zheng Y; Wu J; Zhang Y; Jiang X
    Front Microbiol; 2017; 8():2142. PubMed ID: 29163427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Everolimus in Modulating the Host Immune Responses against
    Raien A; Davis S; Zhang M; Zitser D; Lin M; Pitcher G; Bhalodia K; Subbian S; Venketaraman V
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages.
    Lee HJ; Ko HJ; Kim SH; Jung YJ
    PLoS One; 2019; 14(3):e0199799. PubMed ID: 30865638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibrutinib suppresses intracellular mycobacterium tuberculosis growth by inducing macrophage autophagy.
    Hu Y; Wen Z; Liu S; Cai Y; Guo J; Xu Y; Lin D; Zhu J; Li D; Chen X
    J Infect; 2020 Jun; 80(6):e19-e26. PubMed ID: 32171871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host-Pathogen Dialogues in Autophagy, Apoptosis, and Necrosis during Mycobacterial Infection.
    Kim JK; Silwal P; Jo EK
    Immune Netw; 2020 Oct; 20(5):e37. PubMed ID: 33163245
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulatory Mechanisms of Autophagy-Targeted Antimicrobial Therapeutics Against Mycobacterial Infection.
    Silwal P; Paik S; Kim JK; Yoshimori T; Jo EK
    Front Cell Infect Microbiol; 2021; 11():633360. PubMed ID: 33828998
    [No Abstract]   [Full Text] [Related]  

  • 16. MicroRNA-27a controls the intracellular survival of Mycobacterium tuberculosis by regulating calcium-associated autophagy.
    Liu F; Chen J; Wang P; Li H; Zhou Y; Liu H; Liu Z; Zheng R; Wang L; Yang H; Cui Z; Wang F; Huang X; Wang J; Sha W; Xiao H; Ge B
    Nat Commun; 2018 Oct; 9(1):4295. PubMed ID: 30327467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy induction targeting mTORC1 enhances Mycobacterium tuberculosis replication in HIV co-infected human macrophages.
    Andersson AM; Andersson B; Lorell C; Raffetseder J; Larsson M; Blomgran R
    Sci Rep; 2016 Jun; 6():28171. PubMed ID: 27302320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing host-pathogen interactions for innovative drug discovery and host-directed therapeutics to tackle tuberculosis.
    Saini S; Gangwar A; Sharma R
    Microbiol Res; 2023 Oct; 275():127466. PubMed ID: 37531813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Everolimus Activity against
    Bianco DM; De Maio F; Santarelli G; Palucci I; Salustri A; Bianchetti G; Maulucci G; Citterio F; Sanguinetti M; Tamburrini E; Sali M; Delogu G
    Antibiotics (Basel); 2023 Jan; 12(1):. PubMed ID: 36671372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein Kinase R Restricts the Intracellular Survival of
    Smyth R; Berton S; Rajabalee N; Chan T; Sun J
    Front Microbiol; 2020; 11():613963. PubMed ID: 33552025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.